Delivery Order SPE2DB24D2011-SPE2DB25FBQTG

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.99 firm fixed price delivery order is for the supply of Lyrica 75 mg capsules, a medication used for various conditions including neuropathic pain, fibromyalgia, and epilepsy. The contract has an ultimate completion date of November 20, 2024 and there is no set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. The contract has a ceiling value of $1,182.32 and a completion date of March 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation,...
This federal contract award, valued at $12,109.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a prescription medication used to treat certain types of nerve pain. The award is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This contract is not designated as a set-aside and appears to be part of a...
This federal contract award, valued at $1,221.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 75 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $8,867.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of December 14, 2023 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,182.30, is a delivery order for the provision of Lyrica 75 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.13 firm fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQTG
    Delivery Order

This federal contract award, valued at $1,732.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 75 mg capsules, a prescription medication used to treat nerve pain.

The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely a delivery order issued under that broader IDC contract, allowing AmerisourceBergen to supply a range of pharmaceutical products and medical supplies to support military and other government healthcare programs.

Generated 8/8/25, 10:09 AM